tRFAla-AGC-3-M8 attenuates neuroinflammation and neuronal damage in Alzheimer’s disease via the EphA7-ERK1/2-p70S6K signaling pathway

This study clarifies the specific role of tRF<sup>Ala-AGC-3-M8</sup> in AD pathology and offers a promising target for therapeutic interventions.

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-05-15
DOI
https://doi.org/10.1186/s13195-025-01734-6
Citations
8
Primary Topic
Axon Guidance and Neuronal Signaling
Type
article
Field-Weighted Citation Impact
7.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

tRFAla-AGC-3-M8 attenuates neuroinflammation and neuronal damage in Alzheimer’s disease via the EphA7-ERK1/2-p70S6K signaling pathway

Yudi Li, Wanzhou Zhang, Wanqing Chi, Li Ling et al.
8 citations
Alzheimer s Research & Therapy
Axon Guidance and Neuronal Signaling
7.27
article

tRFAla-AGC-3-M8 attenuates neuroinflammation and neuronal damage in Alzheimer’s disease via the EphA7-ERK1/2-p70S6K signaling pathway

Yudi Li, Wanzhou Zhang, Wanqing Chi, Li Ling, Zihao Deng, Fangming Li
article en
8 citations

Abstract

This study clarifies the specific role of tRF<sup>Ala-AGC-3-M8</sup> in AD pathology and offers a promising target for therapeutic interventions.

Alzheimer s Research & TherapyVol. 17(1)
Third Affiliated Hospital of Southern Medical University (CN), Southern Medical University Shenzhen Hospital (CN), Southern Medical University (CN)
Good health and well-being
Openalex Percentile: Top 2%
Axon Guidance and Neuronal Signaling
7.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.